| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC0712 |
| Trial ID | ACTRN12617001579381 |
| Disease | Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant |
| Year | 2017 |
| Country | Australia |
| Company sponsor | Western Sydney Local Health District, Westmead Hospital |
| Other ID(s) | U1111-1204-6974 |
| Cohort 1 | |||||||||||||
|
|||||||||||||